极品新婚夜少妇真紧,亚洲精品一区二区三区中文字幕 ,久久久久人妻精品一区三寸蜜桃,日韩人妻无码一区二区三区

產(chǎn)品資料

LH-RH (Human)

如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: LH-RH (Human)
產(chǎn)品型號(hào): HOR-261
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無相關(guān)文檔

簡(jiǎn)單介紹

LH-RH (Human)


LH-RH (Human)  的詳細(xì)介紹
  • Product Code: HOR-261
  • Synonyms/Product Alternate Names: Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, Luteinizing Hormone Releasing Hormone Human, Progonadoliberin-1, Progonadoliberin I, LHRH, GRH, GNRH, LNRH.
  • Gonadotropin-releasing hormone 1 (GNRH1), also known as Luteinising-hormone releasing hormone (LHRH), is a peptide hormone responsible for the release of FSH and LH from the anterior pituitary. GNRH1 is synthesized and released by the hypothalamus.

    At the pituitary, GNRH1 stimulates the synthesis and secretion of the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These processes are controlled by the size and frequency of GNRH1 pulses, as well as by feedback from androgens and estrogens. Low requency GNRH1 pulses lead to FSH release, whereas high frequency GNRH1 pulses stimulate LH release.

    There are differences in GNRH1 secretion between males and females. In males, GNRH1 is secreted in pulses at a constant frequency, but in females the frequency of the pulses varies during the menstrual cycle and there is a large surge of GNRH1 just before ovulation.

    GNRH1 secretion is pulsatile in all vertebrates, and is necessary for correct reproductive function. Thus, a single hormone, GNRH1, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male.

    Description: Lutenizing Hormone Releasing Hormone Human Synthetic is a single, non-glycosylated, polypeptide chain containing 10 amino acids and having a molecular mass of 1182.2 Dalton. The molecular formula is C55H75N17O13.C2H4O2. The CAS Number is 71447-49-9.

    Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.

    Formulation: The LHRH was lyophilized from a concentrated (1 mg/ml) solution with no additives.

    Solubility: It is recommended to reconstitute the lyophilized LHRH in sterile 18MΩ-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions. The LHRH is also soluble in a 1% glacial acetic acid.

    Stability: Lyophilized LHRH although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution LNRH should be stored at 4°C between 2-7 days and for future use below -18°C.
    For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
    Please prevent freeze-thaw cycles.

  • Storage Conditions: -20 °C
  • Purity: Greater than 98.0% as determined by RP-HPLC.
  • Molecular Weight: C55H75N17O13.C2H4O2
  • Molecular Formula: 71447-49-9
  • CAS Number: 71447-49-9
產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
相關(guān)產(chǎn)品
[Tyr8]-Substance P (0.5 mg vial) PSP-4059-v
[Val5]-Angiotensin I (Bovine) (Bulk) PAN-4069
[Val5]-Angiotensin I (Bovine) (0.5 mg vial) PAN-4069-v
Bis-ACV PAC-3860-PI
[Arg8]-Vasopressin (0.5 mg vial) PVP-4085-v
[Arg8]-Vasotocin (0.5 mg vial) PVP-4192-v
[Asn1,Val5]-Angiotensin II PAN-4036
[Asn1,Val5]-Angiotensin II (0.5 mg vial) PAN-4036-v
[Asu1,6-Oxytocin (Deamino-Dicarba-Oxytocin) (0.5 mg vial) POX-4025-v
[D-Ala2,D-Leu5]-Enkephalin PEK-4115
[D-Ala2,D-Leu5]-Enkephalin (0.5 mg vial) PEK-4115-v
[D-Ala2,Met5]-Enkephalinamide (0.5 mg vial) PEK-4117-v
[D-Ala2,Met5]-Enkephalin PEK-4116
[D-Ala2,Met5]-Enkephalin (0.5 mg vial) PEK-4116-v
[D-Ala2,Met5]-Enkephalinamide PEK-4117
[Asu1,6,Arg8]-Vasopressin Deamino-Dicarba-Arginine-Vasopressin (0.5 mg vial) PVP-4026-v
[Dap3]-Ghrelin (Human, Rat, 1-5) PGH-3681-PI
[Dap3]-Ghrelin (Rat) PGH-3680-PI
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P PGH-3652-PI
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P PSP-4172
[Asu1,6,Arg8]-Vasotocin (0.5 mg vial) PVP-4027-v
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P (0.5 mg vial) PSP-4172-v
[D-Arg1,D-Trp7,9,Leu11]-Substance P PSP-4173
[D-Arg1,D-Trp7,9,Leu11]-Substance P (0.5 mg vial) PSP-4173-v
[D-Pro2,D-Trp7,9]-Substance P PSP-4113
[D-Pro2,D-Trp7,9]-Substance P (0.5 mg vial) PSP-4113-v
[D-Pro4,Trp7,9]-Substance P (4-11) PSP-4114
[D-Pro4,Trp7,9]-Substance P (4-11) (0.5 mg vial) PSP-4114-v
[D-Trp8]-Somatostatin (0.5 mg vial) PSI-4101-v
[Gly14]-Humanin (0.5 mg vial) PHN-4385-v
[Met(O)12]-ANP (Human, 1-28) (0.5 mg vial) PAF-4145-v
[Nle4, D-Phe7]-?-MSH-Amide PMC-3669-PI
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 1-34 amide) (0.5 mg vial) PTH-4180-v
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 1-34) (0.5 mg vial) PTH-4129-v
[Nle8,18,Tyr34]-Parathyroid Hormone (Human, 3-34 amide) (0.5 mg vial) PTH-4181-v
[Pmp1, Tyr(Me)2]-Arg8-Vasopressin (0.5 mg vial) PVP-4203-v
[Pyr1]-Apelin-13 (Human, Bovine) (0.5 mg vial) PAP-4361-v
[Pyr3]-Amyloid ?-Protein (Human, 3-42) (0.5 mg vial) PAB-4367-v
[Pyr33]-Pancreastatin (Porcine, 33-49) (0.5 mg vial) PPP-4186-v
[Sar1,Ala8]-Angiotensin II PAN-4035
[Sar1,Ala8]-Angiotensin II (0.5 mg vial) PAN-4035-v
[Sar1,Ile8]-Angiotensin II PAN-4016
[Sar1,Ile8]-Angiotensin II (0.5 mg vial) PAN-4016-v
Acetyl-Myelin Basic Protein (Human, Porcine, Rat, 1-11) PMB-3658-PI
Acetyl-Myelin Basic Protein (Mouse, 1-11) PMB-3657-PI
[Leu31, Pro34]-NPY (Porcine) (0.1mg vial) PNP-4314-s
[Sar1,Thr8]-Angiotensin II PAN-4102
[Sar1,Thr8]-Angiotensin II (0.5 mg vial) PAN-4102-v
[Sar1,Val5,Ala8]-Angiotensin II PAN-4071
[Sar1,Val5,Ala8]-Angiotensin II (0.5 mg vial) PAN-4071-v

滬公網(wǎng)安備 31011202007343號(hào)